Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 5Phase 2/3 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Vomiting 2Nausea 2Postoperative Nausea and Vomiting 1Neoplasms 1Muscular Atrophy 1Child Nutrition Disorders 1

Interventions

Olanzapine 2netupitant 1ginger extract 1Therapeutics 1Palonosetron 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Nausea × Olanzapine × Clear all
NCT03631004 2022-01-13

Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients

Instituto do Cancer do Estado de São Paulo

Phase 2/3 Completed
100 enrolled

Nausea, Vomiting, Postoperative Nausea and Vomiting

NCT03137121 2021-08-17

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients

University of Alabama at Birmingham

Phase 2/3 Completed
30 enrolled 9 charts

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡